CL2013002438A1 - Metodo para crear modificación genética en una célula de ganado usando acido nucleico que codifica una molecula efectora y nucleasas efectoras (talens) - Google Patents
Metodo para crear modificación genética en una célula de ganado usando acido nucleico que codifica una molecula efectora y nucleasas efectoras (talens)Info
- Publication number
- CL2013002438A1 CL2013002438A1 CL2013002438A CL2013002438A CL2013002438A1 CL 2013002438 A1 CL2013002438 A1 CL 2013002438A1 CL 2013002438 A CL2013002438 A CL 2013002438A CL 2013002438 A CL2013002438 A CL 2013002438A CL 2013002438 A1 CL2013002438 A1 CL 2013002438A1
- Authority
- CL
- Chile
- Prior art keywords
- effector
- talens
- encodes
- nucleic acid
- genetic modification
- Prior art date
Links
- 239000012636 effector Substances 0.000 title 2
- 241000283690 Bos taurus Species 0.000 title 1
- 101710163270 Nuclease Proteins 0.000 title 1
- 238000012239 gene modification Methods 0.000 title 1
- 230000005017 genetic modification Effects 0.000 title 1
- 235000013617 genetically modified food Nutrition 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0276—Knock-out vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
- A61D19/00—Instruments or methods for reproduction or fertilisation
- A61D19/04—Instruments or methods for reproduction or fertilisation for embryo transplantation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/101—Bovine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/108—Swine
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Environmental Sciences (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Reproductive Health (AREA)
- Public Health (AREA)
- Transplantation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161446651P | 2011-02-25 | 2011-02-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2013002438A1 true CL2013002438A1 (es) | 2014-08-29 |
Family
ID=46719944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2013002438A CL2013002438A1 (es) | 2011-02-25 | 2013-08-23 | Metodo para crear modificación genética en una célula de ganado usando acido nucleico que codifica una molecula efectora y nucleasas efectoras (talens) |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US20120222143A1 (https=) |
| EP (3) | EP3461898A1 (https=) |
| JP (4) | JP2014509195A (https=) |
| KR (1) | KR20140046408A (https=) |
| CN (4) | CN107058383A (https=) |
| AR (1) | AR085507A1 (https=) |
| AU (3) | AU2012222144B2 (https=) |
| BR (1) | BR112013021785A8 (https=) |
| CA (1) | CA2828239C (https=) |
| CL (1) | CL2013002438A1 (https=) |
| EA (1) | EA201391234A1 (https=) |
| MX (2) | MX363013B (https=) |
| WO (1) | WO2012116274A2 (https=) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9790479B2 (en) | 2009-11-02 | 2017-10-17 | University Of Washington | Therapeutic nuclease compositions and methods |
| US10000745B2 (en) | 2009-11-02 | 2018-06-19 | University Of Washington | Therapeutic nuclease compositions and methods |
| US10988745B2 (en) | 2013-10-31 | 2021-04-27 | Resolve Therapeutics, Llc | Therapeutic nuclease-albumin fusions and methods |
| US12077790B2 (en) | 2016-07-01 | 2024-09-03 | Resolve Therapeutics, Llc | Optimized binuclease fusions and methods |
| US12129288B2 (en) | 2017-08-22 | 2024-10-29 | Sanabio, Llc | Polynucleotides heterodimers of soluble interferon receptors and uses thereof |
Families Citing this family (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2533629B1 (en) * | 2010-02-11 | 2018-11-28 | Recombinetics, Inc. | Methods and materials for producing transgenic artiodactyls |
| US10920242B2 (en) | 2011-02-25 | 2021-02-16 | Recombinetics, Inc. | Non-meiotic allele introgression |
| US9528124B2 (en) * | 2013-08-27 | 2016-12-27 | Recombinetics, Inc. | Efficient non-meiotic allele introgression |
| US8497124B2 (en) * | 2011-12-05 | 2013-07-30 | Factor Bioscience Inc. | Methods and products for reprogramming cells to a less differentiated state |
| WO2013106753A1 (en) * | 2012-01-13 | 2013-07-18 | The Board Of Trustees Of The Leland Stanford Junior University | Mechanical biomarkers for oocyte and embryo viability |
| AU2013204327B2 (en) * | 2012-04-20 | 2016-09-01 | Aviagen | Cell transfection method |
| BR112014029417B1 (pt) | 2012-05-25 | 2023-03-07 | Cellectis | Método ex vivo para a preparação de células t para imunoterapia |
| AR091482A1 (es) * | 2012-06-21 | 2015-02-04 | Recombinetics Inc | Celulas modificadas geneticamente y metodos par su obtencion |
| WO2013191769A1 (en) * | 2012-06-22 | 2013-12-27 | Mayo Foundation For Medical Education And Research | Genome editing |
| US10058078B2 (en) | 2012-07-31 | 2018-08-28 | Recombinetics, Inc. | Production of FMDV-resistant livestock by allele substitution |
| GB201216564D0 (en) | 2012-09-17 | 2012-10-31 | Univ Edinburgh | Genetically edited animal |
| AP2015008495A0 (en) * | 2012-10-30 | 2015-05-31 | Ct For Aquaculture Technologies Inc | Control of sexual maturation in animals |
| KR102121086B1 (ko) * | 2012-11-01 | 2020-06-09 | 팩터 바이오사이언스 인크. | 세포에서 단백질을 발현시키는 방법들과 생성물들 |
| CN102964431B (zh) * | 2012-12-03 | 2014-05-07 | 中国农业科学院北京畜牧兽医研究所 | 一对特异识别肌肉生长抑制素基因的多肽及其编码基因和应用 |
| US9708589B2 (en) | 2012-12-18 | 2017-07-18 | Monsanto Technology Llc | Compositions and methods for custom site-specific DNA recombinases |
| WO2014110552A1 (en) * | 2013-01-14 | 2014-07-17 | Recombinetics, Inc. | Hornless livestock |
| US11039586B2 (en) | 2013-03-15 | 2021-06-22 | Monsanto Technology Llc | Creation and transmission of megaloci |
| US10793867B2 (en) | 2013-03-15 | 2020-10-06 | Monsanto Technology, Llc | Methods for targeted transgene-integration using custom site-specific DNA recombinases |
| EP2994531B1 (en) * | 2013-05-10 | 2018-03-28 | Sangamo Therapeutics, Inc. | Delivery methods and compositions for nuclease-mediated genome engineering |
| US11077144B2 (en) | 2013-05-13 | 2021-08-03 | Cellectis | CD19 specific chimeric antigen receptor and uses thereof |
| US20140359796A1 (en) * | 2013-05-31 | 2014-12-04 | Recombinetics, Inc. | Genetically sterile animals |
| US20140359795A1 (en) * | 2013-05-31 | 2014-12-04 | Recombinetics, Inc. | Genetic techniques for making animals with sortable sperm |
| US9982277B2 (en) | 2013-06-11 | 2018-05-29 | The Regents Of The University Of California | Methods and compositions for target DNA modification |
| KR102243597B1 (ko) | 2013-08-16 | 2021-04-26 | 메사추세츠 인스티튜트 오브 테크놀로지 | 세포로의 선택적 물질 전달 |
| US20150064149A1 (en) * | 2013-09-04 | 2015-03-05 | Mice With Horns, LLC. | Materials and methods for correcting recessive mutations in animals |
| DE102013111099B4 (de) | 2013-10-08 | 2023-11-30 | Eberhard Karls Universität Tübingen Medizinische Fakultät | Permanente Genkorrektur mittels nukleotidmodifizierter messenger RNA |
| US10779518B2 (en) | 2013-10-25 | 2020-09-22 | Livestock Improvement Corporation Limited | Genetic markers and uses therefor |
| KR101554166B1 (ko) * | 2013-11-13 | 2015-09-22 | 건국대학교 산학협력단 | 재조합 활성 유전자 2 유전자 적중벡터, 그 벡터가 도입된 면역세포 결핍 형질전환 미니 복제돼지 생산과 그 제조방법 및 활용 |
| KR101566498B1 (ko) * | 2013-11-13 | 2015-11-06 | 건국대학교 산학협력단 | 인터루킨 2 수용체 감마 유전자 적중벡터, 그 벡터가 도입된 면역세포 결핍 형질전환 미니 복제돼지 생산과 그 제조방법 및 활용 |
| DK3492593T3 (da) * | 2013-11-13 | 2021-11-08 | Childrens Medical Center | Nukleasemedieret regulering af genekspression |
| CN103952424B (zh) * | 2014-04-23 | 2017-01-11 | 尹熙俊 | 生产mstn双侧基因敲除的双肌性状体细胞克隆猪的方法 |
| BR112016024945A2 (pt) * | 2014-04-28 | 2017-10-24 | Recombinetics Inc | edição de gene multiplex em suínos |
| CN103952405B (zh) * | 2014-05-13 | 2016-02-10 | 扬州大学 | 一种山羊mstn基因定点修饰系统及其应用 |
| WO2016049182A1 (en) | 2014-09-23 | 2016-03-31 | Aggentics, Inc. | Materials and methods for producing animals with short hair |
| KR20170074235A (ko) | 2014-10-31 | 2017-06-29 | 메사추세츠 인스티튜트 오브 테크놀로지 | 면역 세포로의 생체분자의 전달 |
| WO2016077429A1 (en) * | 2014-11-12 | 2016-05-19 | Recombinetics, Inc. | Heterozygous modifications of tumor suppressor genes and swine model of neurofibromatosis type 1 |
| CN104450673B (zh) * | 2014-11-14 | 2017-07-21 | 中国农业大学 | 一种y染色体修饰方法及其应用 |
| CN104388560B (zh) * | 2014-11-14 | 2017-04-12 | 中国农业大学 | 一种y染色体标记方法及其应用 |
| US20180105834A1 (en) * | 2014-11-27 | 2018-04-19 | Institute Of Animal Sciences, Chinese Academy Of Agrigultural Sciences | A method of site-directed insertion to h11 locus in pigs by using site-directed cutting system |
| KR101724805B1 (ko) * | 2014-12-16 | 2017-04-11 | 서울대학교산학협력단 | 유전자 적중 물질을 이용한 조류 유전자 편집방법 및 유전자 편집 조류 |
| CN107250373A (zh) * | 2015-01-12 | 2017-10-13 | 麻省理工学院 | 通过微流体递送实现的基因编辑 |
| RU2018103093A (ru) * | 2015-06-30 | 2019-07-31 | Реджентс Оф Зэ Юниверсити Оф Миннесота | Гуманизированная скелетная мышца |
| AU2016289530B2 (en) | 2015-07-09 | 2021-05-06 | Massachusetts Institute Of Technology | Delivery of materials to anucleate cells |
| US11339408B2 (en) | 2015-08-20 | 2022-05-24 | Applied Stemcell, Inc. | Nuclease with enhanced efficiency of genome editing |
| EP3344575B1 (en) | 2015-09-04 | 2020-04-15 | SQZ Biotechnologies Company | Intracellular delivery of biomolecules to cells comprising a cell wall |
| KR20180091821A (ko) | 2015-10-27 | 2018-08-16 | 리컴비네틱스 인코포레이티드 | 유전적 상보성에 의한 인간화 car t-세포 및 혈소판의 조작방법 |
| AU2016344609B2 (en) * | 2015-10-28 | 2022-05-12 | Vertex Pharmaceuticals Incorporated | Materials and methods for treatment of duchenne muscular dystrophy |
| CN105543257A (zh) * | 2016-01-18 | 2016-05-04 | 安徽农业大学 | 一种pAPN基因定点修饰猪 |
| KR20230110373A (ko) * | 2016-06-14 | 2023-07-21 | 리전츠 오브 더 유니버스티 오브 미네소타 | 질환을 치료하기 위한 유전적으로 변형된 세포, 조직,및 장기 |
| US11708588B2 (en) * | 2016-06-16 | 2023-07-25 | Adam Brian Robertson | Gene editing |
| US20180084767A1 (en) | 2016-09-21 | 2018-03-29 | Recombinetics, Inc. | Animal models for cardiomyopathy |
| GB201617559D0 (en) | 2016-10-17 | 2016-11-30 | University Court Of The University Of Edinburgh The | Swine comprising modified cd163 and associated methods |
| EP4219709A1 (en) * | 2016-11-03 | 2023-08-02 | Temple University - Of The Commonwealth System of Higher Education | Dna plasmids for the fast generation of homologous recombination vectors for cell line development |
| TW201841916A (zh) | 2017-04-12 | 2018-12-01 | 美商麥珍塔治療學股份有限公司 | 芳香烴受體拮抗劑及其用途 |
| CN108728477B (zh) * | 2017-04-24 | 2022-02-22 | 华东理工大学 | 一种高效的转座突变系统及构建方法 |
| EP3665279B1 (en) * | 2017-08-09 | 2023-07-19 | Benson Hill, Inc. | Compositions and methods for modifying genomes |
| US20190045761A1 (en) | 2017-08-11 | 2019-02-14 | Recombinetics, Inc. | Inducible disease models methods of making them and use in tissue complementation |
| US20190314407A1 (en) | 2017-10-31 | 2019-10-17 | Magenta Therapeutics Inc. | Compositions and methods for the expansion of hematopoietic stem and progenitor cells |
| CN111712262A (zh) | 2017-12-06 | 2020-09-25 | 美真达治疗公司 | 用于动员造血干细胞和祖细胞的给药方案 |
| CN108949830B (zh) * | 2018-08-03 | 2021-11-26 | 福州大学 | 一种在鱼类中实现基因组编辑、精确定点基因敲入的方法 |
| WO2020210237A1 (en) * | 2019-04-08 | 2020-10-15 | Dna Twopointo Inc. | Transposition of nucleic acid constructs into eukaryotic genomes with a transposase from amyelois |
| CN111793654B (zh) * | 2019-04-08 | 2022-05-24 | 中国农业大学 | 一种提高CRISPR/Cas9介导的双等位基因突变效率的方法及其应用 |
| EP4051298A1 (en) | 2019-11-01 | 2022-09-07 | Magenta Therapeutics, Inc. | Dosing regimens for the mobilization of hematopoietic stem and progentor cells |
| CA3176979A1 (en) | 2020-04-27 | 2021-11-04 | Anthony Boitano | Methods and compositions for transducing hematopoietic stem and progenitor cells in vivo |
| WO2022197776A1 (en) | 2021-03-16 | 2022-09-22 | Magenta Therapeutics, Inc. | Dosing regimens for hematopoietic stem cell mobilization for stem cell transplants in multiple myeloma patients |
| GB202118058D0 (en) | 2021-12-14 | 2022-01-26 | Univ Warwick | Methods to increase yields in crops |
| WO2023150503A2 (en) * | 2022-02-01 | 2023-08-10 | Abs Global, Inc. | Gene-editing methods for embryonic stem cells |
| GB2621813A (en) | 2022-06-30 | 2024-02-28 | Univ Newcastle | Preventing disease recurrence in Mitochondrial replacement therapy |
| WO2024036106A1 (en) * | 2022-08-08 | 2024-02-15 | The Board Of Trustees Of The Leland Stanford Junior University | Embryo microglia complementation for in vivo microglia manipulation and production of a non-human animal model for validation of gene function and therapeutic screening |
| GB202314578D0 (en) | 2023-09-22 | 2023-11-08 | Univ Manchester | Methods of producing homoplasmic modified plants or parts thereof |
Family Cites Families (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4873191A (en) | 1981-06-12 | 1989-10-10 | Ohio University | Genetic transformation of zygotes |
| US4888274A (en) | 1985-09-18 | 1989-12-19 | Yale University | RecA nucleoprotein filament and methods |
| US5731178A (en) | 1990-03-21 | 1998-03-24 | Behringwerke Aktiengesellschaft | Attachment-elements for stimulation of eukaryotic expression systems |
| US5510473A (en) | 1990-11-09 | 1996-04-23 | The United States Of American As Represented By The Secretary Of Health And Human Services | Cloning of the recA gene from thermus aquaticus YT-1 |
| US5763240A (en) | 1992-04-24 | 1998-06-09 | Sri International | In vivo homologous sequence targeting in eukaryotic cells |
| US5674992A (en) | 1992-08-28 | 1997-10-07 | Cornell Research Foundation, Inc. | CDNA encoding a recA homolog in eukaryotes |
| US5610053A (en) | 1993-04-07 | 1997-03-11 | The United States Of America As Represented By The Department Of Health And Human Services | DNA sequence which acts as a chromatin insulator element to protect expressed genes from cis-acting regulatory sequences in mammalian cells |
| US5731411A (en) | 1993-07-12 | 1998-03-24 | The United States Of America As Represented By The Department Of Health And Human Services | Promotion of homologous DNA pairing by RecA-derived peptides |
| EP0821070A1 (en) | 1996-07-22 | 1998-01-28 | Carelli, Claude Marcel Henri | Pit-1 gene polymorphism and trait selection in animals |
| US6037525A (en) | 1996-08-01 | 2000-03-14 | North Carolina State University | Method for reducing expression variability of transgenes in plant cells |
| US5948653A (en) | 1997-03-21 | 1999-09-07 | Pati; Sushma | Sequence alterations using homologous recombination |
| AU756620B2 (en) * | 1997-07-14 | 2003-01-16 | University Of Liege | Mutations in the myostation gene cause double-muscling in mammals |
| US6541684B1 (en) | 1998-02-13 | 2003-04-01 | Trustees Of Columbia University In The City Of New York | Nucleotide sequences encoding maize RAD51 |
| US6388169B1 (en) | 1998-06-08 | 2002-05-14 | Pioneer Hi-Bred International, Inc. | Maize orthologues of bacterial RecA proteins |
| US6774213B1 (en) | 1998-07-24 | 2004-08-10 | Alberto I. Roca | Mutants of MAW motifs of RecA protein homologs, methods of making them, and their uses |
| WO2000011155A1 (en) | 1998-08-19 | 2000-03-02 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for genomic modification |
| GB2365445A (en) | 1998-10-12 | 2002-02-20 | Geron Bio Med Ltd | Porcine occcytes with improved developmental competence |
| WO2000023606A1 (en) | 1998-10-22 | 2000-04-27 | Medical College Of Georgia Institute, Inc. | Long terminal repeat, enhancer, and insulator sequences for use in recombinant vectors |
| US6720478B1 (en) | 1999-05-05 | 2004-04-13 | Pioneer Hi-Bred International, Inc. | RAD51-like polynucleotide and uses thereof |
| EP1198169B1 (en) * | 1999-05-06 | 2008-05-07 | Stem Cell Sciences (Australia) Pty Ltd | A process of cell reprogramming through production of a heterokaryon |
| WO2001030965A2 (en) | 1999-10-28 | 2001-05-03 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of in vivo gene transfer using a sleeping beauty transposon system |
| US6686515B1 (en) | 1999-11-23 | 2004-02-03 | Maxygen, Inc. | Homologous recombination in plants |
| ES2355493T3 (es) | 2000-02-18 | 2011-03-28 | The Board Of Trustees Of The Leland Stanford Junior University | Recombinasas alteradas para la modificación del genoma. |
| DK1311661T3 (da) | 2000-08-14 | 2012-11-26 | Us Gov Health & Human Serv | Forøget homolog rekombination medieret ved lambda-rekombinationsproteiner |
| US7199281B2 (en) | 2001-09-07 | 2007-04-03 | The Regents Of The University Of California | Method of generating a transgenic livestock animal |
| WO2003080809A2 (en) * | 2002-03-21 | 2003-10-02 | Sangamo Biosciences, Inc. | Methods and compositions for using zinc finger endonucleases to enhance homologous recombination |
| US7176007B2 (en) | 2002-12-12 | 2007-02-13 | Wisconsin Alumni Research Foundation | RecA mutants |
| US7468248B2 (en) | 2002-12-31 | 2008-12-23 | Cargill, Incorporated | Methods and systems for inferring bovine traits |
| US20040203158A1 (en) | 2003-01-15 | 2004-10-14 | Hackett Perry B. | Transposon-insulator element delivery systems |
| US7985739B2 (en) | 2003-06-04 | 2011-07-26 | The Board Of Trustees Of The Leland Stanford Junior University | Enhanced sleeping beauty transposon system and methods for using the same |
| US20050153317A1 (en) | 2003-10-24 | 2005-07-14 | Metamorphix, Inc. | Methods and systems for inferring traits to breed and manage non-beef livestock |
| AU2005237494B2 (en) * | 2004-04-22 | 2010-06-10 | Kyowa Hakko Kirin Co., Ltd | Transgenic animals and uses thereof |
| CA2958259C (en) * | 2004-10-22 | 2020-06-30 | Revivicor, Inc. | Ungulates with genetically modified immune systems |
| WO2008060510A2 (en) * | 2006-11-13 | 2008-05-22 | Sangamo Biosciences, Inc. | Zinc finger nuclease for targeting the human glucocorticoid receptor locus |
| WO2010008564A2 (en) | 2008-07-16 | 2010-01-21 | Recombinetics | Plaice dna transposon system |
| WO2010008562A2 (en) | 2008-07-16 | 2010-01-21 | Recombinetics | Methods and materials for producing transgenic animals |
| SG191561A1 (en) * | 2008-08-22 | 2013-07-31 | Sangamo Biosciences Inc | Methods and compositions for targeted single-stranded cleavage and targeted integration |
| US20110023158A1 (en) * | 2008-12-04 | 2011-01-27 | Sigma-Aldrich Co. | Bovine genome editing with zinc finger nucleases |
| US20110023140A1 (en) | 2008-12-04 | 2011-01-27 | Sigma-Aldrich Co. | Rabbit genome editing with zinc finger nucleases |
| EP2206723A1 (en) * | 2009-01-12 | 2010-07-14 | Bonas, Ulla | Modular DNA-binding domains |
| KR20100133319A (ko) * | 2009-06-11 | 2010-12-21 | 주식회사 툴젠 | 표적 특이적인 게놈의 재배열을 위한 표적 특이적 뉴클레아제 및 이의 용도 |
| EP2456877A4 (en) * | 2009-07-24 | 2012-05-30 | Sigma Aldrich Co Llc | METHOD OF GENOMIC PROCESSING |
| WO2011017315A2 (en) * | 2009-08-03 | 2011-02-10 | Recombinetics, Inc. | Methods and compositions for targeted gene modification |
| US8586526B2 (en) * | 2010-05-17 | 2013-11-19 | Sangamo Biosciences, Inc. | DNA-binding proteins and uses thereof |
| JP5940977B2 (ja) * | 2009-08-11 | 2016-06-29 | サンガモ バイオサイエンシーズ, インコーポレイテッド | 標的改変によるホモ接合生物 |
| WO2011072246A2 (en) * | 2009-12-10 | 2011-06-16 | Regents Of The University Of Minnesota | Tal effector-mediated dna modification |
| EP2533629B1 (en) | 2010-02-11 | 2018-11-28 | Recombinetics, Inc. | Methods and materials for producing transgenic artiodactyls |
-
2012
- 2012-02-24 MX MX2013009725A patent/MX363013B/es unknown
- 2012-02-24 EA EA201391234A patent/EA201391234A1/ru unknown
- 2012-02-24 EP EP18204730.8A patent/EP3461898A1/en not_active Withdrawn
- 2012-02-24 JP JP2013555596A patent/JP2014509195A/ja active Pending
- 2012-02-24 CN CN201611152146.3A patent/CN107058383A/zh active Pending
- 2012-02-24 EP EP18199895.6A patent/EP3450563A1/en not_active Withdrawn
- 2012-02-24 CN CN201280020439.XA patent/CN103930550B/zh active Active
- 2012-02-24 CN CN201610545840.5A patent/CN106417184A/zh active Pending
- 2012-02-24 EP EP12749281.7A patent/EP2678434B1/en active Active
- 2012-02-24 BR BR112013021785A patent/BR112013021785A8/pt not_active Application Discontinuation
- 2012-02-24 WO PCT/US2012/026500 patent/WO2012116274A2/en not_active Ceased
- 2012-02-24 KR KR1020137025161A patent/KR20140046408A/ko not_active Ceased
- 2012-02-24 CN CN201611151706.3A patent/CN107090470B/zh active Active
- 2012-02-24 CA CA2828239A patent/CA2828239C/en active Active
- 2012-02-24 US US13/404,662 patent/US20120222143A1/en not_active Abandoned
- 2012-02-24 AU AU2012222144A patent/AU2012222144B2/en active Active
- 2012-02-28 AR ARP120100647A patent/AR085507A1/es not_active Application Discontinuation
- 2012-08-24 US US13/594,694 patent/US20130117870A1/en not_active Abandoned
-
2013
- 2013-08-23 MX MX2019002482A patent/MX2019002482A/es unknown
- 2013-08-23 CL CL2013002438A patent/CL2013002438A1/es unknown
-
2014
- 2014-08-15 US US14/460,841 patent/US20140351965A1/en not_active Abandoned
-
2017
- 2017-04-11 AU AU2017202379A patent/AU2017202379B2/en active Active
- 2017-05-09 JP JP2017093110A patent/JP2017184743A/ja active Pending
- 2017-05-09 JP JP2017093111A patent/JP2017184744A/ja active Pending
-
2019
- 2019-08-23 JP JP2019152894A patent/JP2020010692A/ja active Pending
- 2019-11-14 AU AU2019264610A patent/AU2019264610A1/en not_active Abandoned
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9790479B2 (en) | 2009-11-02 | 2017-10-17 | University Of Washington | Therapeutic nuclease compositions and methods |
| US10000745B2 (en) | 2009-11-02 | 2018-06-19 | University Of Washington | Therapeutic nuclease compositions and methods |
| US11306297B2 (en) | 2009-11-02 | 2022-04-19 | University Of Washington | Therapeutic nuclease compositions and methods |
| US12435322B2 (en) | 2009-11-02 | 2025-10-07 | University Of Washington | Therapeutic nuclease compositions and methods |
| US10202588B2 (en) | 2011-04-29 | 2019-02-12 | The University Of Washington | Therapeutic nuclease compositions and methods |
| US11034944B2 (en) | 2011-04-29 | 2021-06-15 | University Of Washington | Therapeutic nuclease compositions and methods |
| US12338466B2 (en) | 2011-04-29 | 2025-06-24 | University Of Washington | Therapeutic nuclease compositions and methods |
| US10988745B2 (en) | 2013-10-31 | 2021-04-27 | Resolve Therapeutics, Llc | Therapeutic nuclease-albumin fusions and methods |
| US12163165B2 (en) | 2013-10-31 | 2024-12-10 | Resolve Therapeutics, Llc | Nucleic acid molecules encoding nuclease-albumin fusion proteins |
| US12077790B2 (en) | 2016-07-01 | 2024-09-03 | Resolve Therapeutics, Llc | Optimized binuclease fusions and methods |
| US12129288B2 (en) | 2017-08-22 | 2024-10-29 | Sanabio, Llc | Polynucleotides heterodimers of soluble interferon receptors and uses thereof |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2013002438A1 (es) | Metodo para crear modificación genética en una célula de ganado usando acido nucleico que codifica una molecula efectora y nucleasas efectoras (talens) | |
| PT3272861T (pt) | Construção de ácido nucleico para expressão de alfα-galactosidase em plantas e células de plantas | |
| GB2513793B (en) | Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library generation | |
| CO6821890A2 (es) | Microorganismos para producir ácido metacrílico y ésteres de metacrilato y métodos relacionados | |
| BR112013024467A2 (pt) | método e composições direcionadas para células adiposas em mamíferos | |
| BR112013014814A2 (pt) | processo para produzir ácido acético | |
| BR112014012681A8 (pt) | polipeptídeo, métido para proporcionar um polipeptídeo, ácido nucleico, e, composição imunogênica | |
| CL2014002018A1 (es) | Molécula de ácido nucleico que comprende una secuencia sintética variante de la enzima 5-enolpiruvil shikimato-3-fosfato sintasa para expresión en una planta; vector; célula huesped; método para producir una planta resistente al glifosato y métodos asociados. | |
| BRPI0906795A2 (pt) | Método para produzir um l-aminoácido | |
| BRPI0918299A2 (pt) | Método para produzir um l-aminoácido | |
| EP2675918A4 (en) | COMPOSITIONS AND METHODS FOR DELIVERING NUCLEIC ACID TO A CELL | |
| ZA201403601B (en) | Systems and methods for engineering nucleic acid constructs using scoring techniques | |
| BR112012032172A2 (pt) | método para produzir um álcool e composição | |
| SG11201605344YA (en) | Analysis of nucleic acids associated with single cells using nucleic acid barcodes | |
| BRPI0912755A2 (pt) | Método para produzir um l-aminoácido | |
| BR112014023405A2 (pt) | nanopartícula de derivado de quitosana, composição compreendendo a nanopartícula e método in vitro para distribuir molécula de ácido nucleico a uma célula | |
| BR112013008068A2 (pt) | método para reduzir o estresse hídrico em plantas | |
| FI20116334L (fi) | Eukaryottiset solut ja menetelmä glykolihapon valmistamiseksi | |
| BR112013014103A2 (pt) | método para produzir um l-aminoácido | |
| IL228785B (en) | Method and module for connecting two energy storage assemblies | |
| BR112014012918A2 (pt) | processo para preparar um sal de ácido, ácido, sal de sódio ácido, e, uso de um ácido | |
| CL2014001740A1 (es) | Molecula de acido nucleico codificante para una proteina que confiere resistencia a plagas; vector; celula huesped; construccion; y metodo de produccion de una planta transgenica. | |
| BR112013032013A2 (pt) | método para seleção de tamanho de ácidos nucleidos, aparelho para seleção de tamanho de ácidos nucleidos e cassete para uso na eletroforese de ácidos nucleidos | |
| BRPI0908337A2 (pt) | Método para purificar ácido metacrílico | |
| BRPI1014579A2 (pt) | método de transferência de polipeptídeo para células |